{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:59:43Z","timestamp":1785117583441,"version":"3.55.0"},"reference-count":33,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Society of Cardiology","award":["CSC2023A03"],"award-info":[{"award-number":["CSC2023A03"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070301"],"award-info":[{"award-number":["82070301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270345"],"award-info":[{"award-number":["82270345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Bureau","doi-asserted-by":"crossref","award":["2024-1-2061"],"award-info":[{"award-number":["2024-1-2061"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Medical Management Center: Yangfan Program","award":["YGLX202324"],"award-info":[{"award-number":["YGLX202324"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Heart failure (HF) is a heterogeneous syndrome affecting over 60 million individuals globally. Patients with hypertension are particularly susceptible to developing HF. Therefore, timely identification and predictive assessment of HF risk have significant clinical implications in this population. Thus, this study aimed to develop a new interpretable machine learning (ML) model for HF prediction. Methods: Using data from the Systolic Blood Pressure Intervention Trial (SPRINT), a random under-sampling technique was applied to address class imbalance in the target variable, achieving a 1:1 ratio between positive and negative samples. By randomly matching 162 individuals without HF events to those with events, a balanced dataset comprising 324 participants was constructed. The test set comprised 40% of the total dataset to ensure a robust evaluation of model performance. Seven ML algorithms, including support vector machine (SVM), adaptive boosting (Adaboost), na\u00efve Bayes (NB), logistic regression (LR), gradient boosting machine (GBM), random forest (RF), and multilayer perceptron (MLP), were employed to construct the predictive models. Model performance was evaluated using the area under the curve (AUC), decision curve analysis (DCA), calibration curves, and other metrics. The SHapley Additive exPlanations (SHAP) approach was employed to rank feature significance and provide interpretability for the final model. Results: Over a median follow-up of 3.88years, 162 patients (1.8%) developed incident HF. Among the seven ML models, GBM demonstrated the best performance. A total of 14 features were retained after the least absolute shrinkage and selection operator (LASSO) selection. The final model exhibited robust predictive capability for identifying HF risk, with an overall accuracy of 0.731, a precision of 0.770, and an AUC (95% confidence interval (CI)) of 0.763 (0.676\u20130.840). Conclusion: The GBM-based explainable prediction model demonstrated robust performance in predicting HF risk among patients with hypertension.<\/jats:p>","DOI":"10.31083\/rcm46901","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:28:22Z","timestamp":1785115702000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification and Validation of an Explainable Predictive Model For Heart Failure in Patients With Hypertension"],"prefix":"10.31083","volume":"27","author":[{"given":"Jiayi","family":"Han","sequence":"first","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengxiao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncong","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfei","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-2321","authenticated-orcid":true,"given":"Yaodong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-0799","authenticated-orcid":true,"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, et al. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet (London, England). 2024; 404: 245\u2013255.","DOI":"10.1016\/S0140-6736(24)01028-6"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016; 134: e535\u2013e578.","DOI":"10.1161\/CIR.0000000000000450"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996; 275: 1557\u20131562.","DOI":"10.1001\/jama.1996.03530440037034"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Archives of Internal Medicine. 1993; 153: 598\u2013615.","DOI":"10.1001\/archinte.153.5.598"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Gallo G, Savoia C. Hypertension and Heart Failure: From Pathophysiology to Treatment. International Journal of Molecular Sciences. 2024; 25: 6661.","DOI":"10.3390\/ijms25126661"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ng K, Steinhubl SR, deFilippi C, Dey S, Stewart WF. Early Detection of Heart Failure Using Electronic Health Records: Practical Implications for Time Before Diagnosis, Data Diversity, Data Quantity, and Data Density. Circulation. Cardiovascular Quality and Outcomes. 2016; 9: 649\u2013658.","DOI":"10.1161\/CIRCOUTCOMES.116.002797"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rasmy L, Wu Y, Wang N, Geng X, Zheng WJ, Wang F, et al. A study of generalizability of recurrent neural network-based predictive models for heart failure onset risk using a large and heterogeneous EHR data set. Journal of Biomedical Informatics. 2018; 84: 11\u201316.","DOI":"10.1016\/j.jbi.2018.06.011"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Choi E, Schuetz A, Stewart WF, Sun J. Using recurrent neural network models for early detection of heart failure onset. Journal of the American Medical Informatics Association: JAMIA. 2017; 24: 361\u2013370.","DOI":"10.1093\/jamia\/ocw112"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Yuan H, Fan XS, Jin Y, He JX, Gui Y, Song LY, et al. Development of heart failure risk prediction models based on a multi-marker approach using random forest algorithms. Chinese Medical Journal. 2019; 132: 819\u2013826.","DOI":"10.1097\/CM9.0000000000000149"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Segar MW, Vaduganathan M, Patel KV, McGuire DK, Butler J, Fonarow GC, et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care. 2019; 42: 2298\u20132306.","DOI":"10.2337\/dc19-0587"},{"key":"ref11","unstructured":"Yang X, Gong Y, Waheed N, March K, Bian J, Hogan WR, et al. Identifying Cancer Patients at Risk for Heart Failure Using Machine Learning Methods. AMIA \u2026 Annual Symposium Proceedings. AMIA Symposium. 2020; 2019: 933\u2013941."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Katz DH, Deo RC, Aguilar FG, Selvaraj S, Martinez EE, Beussink-Nelson L, et al. Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction. Journal of Cardiovascular Translational Research. 2017; 10: 275\u2013284.","DOI":"10.1007\/s12265-017-9739-z"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nature Reviews. Molecular Cell Biology. 2022; 23: 40\u201355.","DOI":"10.1038\/s41580-021-00407-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Camacho DM, Collins KM, Powers RK, Costello JC, Collins JJ. Next-Generation Machine Learning for Biological Networks. Cell. 2018; 173: 1581\u20131592.","DOI":"10.1016\/j.cell.2018.05.015"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Khan MS, Arshad MS, Greene SJ, Van Spall HGC, Pandey A, Vemulapalli S, et al. Artificial intelligence and heart failure: A state-of-the-art review. European Journal of Heart Failure. 2023; 25: 1507\u20131525.","DOI":"10.1002\/ejhf.2994"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Azodi CB, Tang J, Shiu SH. Opening the Black Box: Interpretable Machine Learning for Geneticists. Trends in Genetics: TIG. 2020; 36: 442\u2013455.","DOI":"10.1016\/j.tig.2020.03.005"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"SPRINT Research Group, Wright JT, Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine. 2015; 373: 2103\u20132116.  Erratum in: The New England Journal of Medicine. 2017; 377: 2506. https:\/\/doi.org\/10.1056\/NEJMx170008.","DOI":"10.1056\/NEJMoa1511939"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, et al. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine. 2021; 384: 1921\u20131930.","DOI":"10.1056\/NEJMoa1901281"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Ruiz-Hurtado G, Banegas JR, Sarafidis PA, Volpe M, Williams B, Ruilope LM. Has the SPRINT trial introduced a new blood-pressure goal in hypertension? Nature Reviews. Cardiology. 2017; 14: 560\u2013566.","DOI":"10.1038\/nrcardio.2017.74"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, et al. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circulation. Heart Failure. 2012; 5: 152\u2013159.","DOI":"10.1161\/CIRCHEARTFAILURE.111.963199"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145: e895\u2013e1032.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"ref22","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In 31st conference on neural information processing systems (NIPS 2017). Long Beach, CA, USA. 2017."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Dhingra LS, Aminorroaya A, Pedroso AF, Khunte A, Sangha V, McIntyre D, et al. Artificial Intelligence-Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms. JAMA Cardiology. 2025; 10: 574\u2013584.","DOI":"10.1001\/jamacardio.2025.0492"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Liu X, Xie Z, Zhang Y, Huang J, Kuang L, Li X, et al. Machine learning for predicting in-hospital mortality in elderly patients with heart failure combined with hypertension: a multicenter retrospective study. Cardiovascular Diabetology. 2024; 23: 407.","DOI":"10.1186\/s12933-024-02503-9"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"G-CHF Investigators, Joseph P, Roy A, Lonn E, St\u00f6rk S, Floras J, et al. Global Variations in Heart Failure Etiology, Management, and Outcomes. JAMA. 2023; 329: 1650\u20131661.","DOI":"10.1001\/jama.2023.5942"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018; 138: 861\u2013870.","DOI":"10.1161\/CIRCULATIONAHA.118.034646"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Yu Q, Hou Z, Wang Z. Predictive modeling of preoperative acute heart failure in older adults with hypertension: a dual perspective of SHAP values and interaction analysis. BMC Medical Informatics and Decision Making. 2024; 24: 329.","DOI":"10.1186\/s12911-024-02734-6"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Li Y, Sperrin M, Ashcroft DM, van Staa TP. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar. BMJ (Clinical Research Ed.). 2020; 371: m3919.","DOI":"10.1136\/bmj.m3919"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023; 329: 827\u2013838.","DOI":"10.1001\/jama.2023.2020"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Messerli FH, Rimoldi SF, Bangalore S. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC. Heart Failure. 2017; 5: 543\u2013551.","DOI":"10.1016\/j.jchf.2017.04.012"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nature Reviews. Nephrology. 2016; 12: 610\u2013623.","DOI":"10.1038\/nrneph.2016.113"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Damman K, Valente MAE, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. European Heart Journal. 2014; 35: 455\u2013469.","DOI":"10.1093\/eurheartj\/eht386"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Zhang Y, Han X, Feng T, Li Z, Yu H, Chen Y, et al. Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease. Cell Host & Microbe. 2025; 33: 1715\u20131730.e5.","DOI":"10.1016\/j.chom.2025.08.014"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/5\/10.31083\/RCM46901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:29:13Z","timestamp":1785115753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/5\/10.31083\/RCM46901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)02865-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm46901","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"46901"}}